• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

针对确诊为I期乳腺癌的老年女性的辅助放疗决策辅助工具的开发与测试:一项试点研究。

Development and Testing of an Adjuvant Radiotherapy Decision Aid for Older Women Diagnosed with Stage I Breast Cancer: A Pilot Study.

作者信息

Neve Matt, Henry-Noel Nayanee, Mehta Rajin, Trudeau Maureen, Menjak Ines, Szumacher Ewa

机构信息

Radiation Oncology, Sunnybrook Health Sciences Centre, Toronto, CAN.

Neuroscience and Health Studies, Population Health (Science), University of Toronto, Toronto, CAN.

出版信息

Cureus. 2020 Apr 16;12(4):e7690. doi: 10.7759/cureus.7690.

DOI:10.7759/cureus.7690
PMID:32440378
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7237198/
Abstract

Background Whole breast irradiation therapy (WBRT), accelerated partial breast irradiation (APBI), and omission of radiotherapy (ORT) are options for women aged 65 years and older with low-risk breast cancer post lumpectomy. Aim The aim of the study was to develop and pilot a decision aid pamphlet (DA), among women aged 65 years and older with low-risk breast cancer and who were undergoing or had undergone WBRT, to ensure they were fully informed about the different options for radiation treatment following lumpectomy. Methods We piloted the decision aid with 40 participants, women aged 65-86 years with low-risk breast cancer and who had undergone or were undergoing WBRT. The women completed a pre-DA Decisional Conflict Scale (DCS) and post-DA DCS, Knowledge, Preparation for Decision-Making and Acceptability questionnaires. We then used descriptive statistics to compare the DCS scores before and after distributing the decision aid. Results The median age of the 40 participants was 72 years (range, 65-86 years), 38% less than 70, 48% between 70 and 80 and 15% over 80. Ethnicity included 53% Caucasians and the remaining 48% African-Americans, Asians, Europeans, and others. Thirty-three percent completed high school, 25% college/university, and 7.5% elementary education. Seventy-eight percent had T1 and 23% T2 breast cancer. Thirty-three percent completed RT less than one year prior to the study, 30% between one to two years, and 38% greater than two years. The median pre-DA DCS score was 31.2 (31.2-90.6), and the median post-DA DCS score was 23.4 (0-75.0). Six (6/40) patients scored 0 on the DCS post intervention, while 13 (13/40) scored less than 15.6. The median knowledge score was 70%. Preparation for decision-making median score was 90%. Ninety-nine percent stated that the DA was useful for future patients.  Conclusion We piloted a DA that aimed to provide the necessary information for women aged 65 years and older with low-risk breast cancer, to understand radiation treatment options post lumpectomy. The results obtained from the study highlighted the utility of the DA in increasing patient comprehension about the different treatment options, reducing decisional conflict in terms of perceptions of uncertainty and preparing patients to engage with their radiation oncologist during the treatment decision-making process. Ultimately, this study promoted the importance of patient-centered care in geriatric oncology by piloting this DA to see its effectiveness while also being responsive to patient's thoughts regarding the tool, so as to have their values guide its further development.

摘要

背景 全乳照射疗法(WBRT)、加速部分乳腺照射(APBI)以及省略放射治疗(ORT)是65岁及以上低风险乳腺癌患者保乳术后的治疗选择。目的 本研究的目的是为65岁及以上低风险乳腺癌且正在接受或已经接受过WBRT的女性开发并试行一份决策辅助手册(DA),以确保她们充分了解保乳术后不同的放射治疗选择。方法 我们对40名参与者试行该决策辅助工具,这些女性年龄在65 - 86岁之间,患有低风险乳腺癌,且已经接受或正在接受WBRT。这些女性完成了DA前的决策冲突量表(DCS)以及DA后的DCS、知识、决策准备和可接受性问卷。然后我们使用描述性统计来比较发放决策辅助工具前后的DCS分数。结果 40名参与者的中位年龄为72岁(范围65 - 86岁),38%小于70岁,48%在70至80岁之间,15%超过80岁。种族包括53%的白种人,其余48%为非裔美国人、亚洲人、欧洲人和其他人。33%完成了高中学业,25%完成了大专/大学学业,7.5%完成了小学教育。78%患有T1期乳腺癌,23%患有T2期乳腺癌。33%在研究前不到一年完成放疗,30%在一至两年之间,38%超过两年。DA前DCS分数的中位数为31.2(31.2 - 90.6),DA后DCS分数的中位数为23.4(0 - 75.0)。6名(6/40)患者在干预后DCS得分为0,而13名(13/40)患者得分低于15.6。知识分数的中位数为70%。决策准备分数的中位数为90%。99%的人表示该DA对未来患者有用。结论 我们试行的一份DA旨在为65岁及以上低风险乳腺癌女性提供必要信息,使其了解保乳术后的放射治疗选择。该研究获得的结果突出了DA在提高患者对不同治疗选择的理解、减少决策不确定性方面的冲突以及使患者在治疗决策过程中做好与放疗肿瘤学家沟通准备方面的作用。最终,本研究通过试行该DA以观察其有效性,同时回应患者对该工具的想法,从而以患者的价值观指导其进一步发展,凸显了老年肿瘤学中以患者为中心的护理的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3ad/7237198/8bc81c01d8e4/cureus-0012-00000007690-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3ad/7237198/a7a084a9504c/cureus-0012-00000007690-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3ad/7237198/721e71eba35a/cureus-0012-00000007690-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3ad/7237198/1c2a7685258c/cureus-0012-00000007690-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3ad/7237198/8bc81c01d8e4/cureus-0012-00000007690-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3ad/7237198/a7a084a9504c/cureus-0012-00000007690-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3ad/7237198/721e71eba35a/cureus-0012-00000007690-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3ad/7237198/1c2a7685258c/cureus-0012-00000007690-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3ad/7237198/8bc81c01d8e4/cureus-0012-00000007690-i04.jpg

相似文献

1
Development and Testing of an Adjuvant Radiotherapy Decision Aid for Older Women Diagnosed with Stage I Breast Cancer: A Pilot Study.针对确诊为I期乳腺癌的老年女性的辅助放疗决策辅助工具的开发与测试:一项试点研究。
Cureus. 2020 Apr 16;12(4):e7690. doi: 10.7759/cureus.7690.
2
Randomized controlled trial on the effect of an online decision aid for young female cancer patients regarding fertility preservation.随机对照试验研究在线决策辅助工具对年轻女性癌症患者生育力保存的效果。
Hum Reprod. 2019 Sep 29;34(9):1726-1734. doi: 10.1093/humrep/dez136.
3
Development of patients' decision aid for older women with stage I breast cancer considering radiotherapy after lumpectomy.发展考虑保乳术后放疗的Ⅰ期乳腺癌老年女性患者的决策辅助工具。
Int J Radiat Oncol Biol Phys. 2012 Sep 1;84(1):30-8. doi: 10.1016/j.ijrobp.2011.11.028. Epub 2012 Feb 11.
4
Implementation of a Novel Patient Decision Aid for Women with Elevated Breast Cancer Risk Who Are Considering MRI Screening: A Pilot Study.实施一种新的患者决策辅助工具,用于考虑接受 MRI 筛查的乳腺癌风险升高的女性:一项试点研究。
Ann Surg Oncol. 2023 Oct;30(10):6152-6158. doi: 10.1245/s10434-023-13901-w. Epub 2023 Jul 28.
5
Acceptability of a patient decision aid for women aged 70 and older with stage I, estrogen receptor-positive, HER2-negative breast cancer.70 岁及以上 I 期、雌激素受体阳性、HER2 阴性乳腺癌女性患者决策辅助工具的可接受性。
J Geriatr Oncol. 2021 Jun;12(5):724-730. doi: 10.1016/j.jgo.2021.02.028. Epub 2021 Mar 5.
6
Improving treatment decision-making in bipolar II disorder: a phase II randomised controlled trial of an online patient decision-aid.改善双相情感障碍 II 型的治疗决策:一项在线患者决策辅助工具的 II 期随机对照试验。
BMC Psychiatry. 2020 Sep 17;20(1):447. doi: 10.1186/s12888-020-02845-0.
7
8
Decision aid for women with newly diagnosed breast cancer seeking breast reconstruction surgery: A prospective, randomized, controlled, single-blinded, pilot study.为寻求乳房重建手术的新诊断乳腺癌女性提供的决策辅助工具:一项前瞻性、随机、对照、单盲的试点研究。
J Plast Reconstr Aesthet Surg. 2021 Oct;74(10):2519-2526. doi: 10.1016/j.bjps.2021.03.029. Epub 2021 Mar 28.
9
Developing a patient decision aid for women aged 70 and older with early stage, estrogen receptor positive, HER2 negative, breast cancer.为 70 岁及以上、早期、雌激素受体阳性、HER2 阴性乳腺癌女性开发患者决策辅助工具。
J Geriatr Oncol. 2019 Nov;10(6):980-986. doi: 10.1016/j.jgo.2019.05.004. Epub 2019 May 24.
10

本文引用的文献

1
Accelerated Partial Breast Irradiation: Executive summary for the update of an ASTRO Evidence-Based Consensus Statement.加速部分乳腺照射:美国放射肿瘤学会循证共识声明更新版执行摘要
Pract Radiat Oncol. 2017 Mar-Apr;7(2):73-79. doi: 10.1016/j.prro.2016.09.007. Epub 2016 Sep 17.
2
5-year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: a randomised, phase 3, non-inferiority trial.5 年结果:保乳手术后采用单纯间质内多导管近距离放疗与全乳放疗加局部推量治疗低危型女性乳腺浸润性癌和原位癌的对比:一项随机、3 期、非劣效性试验。
Lancet. 2016 Jan 16;387(10015):229-38. doi: 10.1016/S0140-6736(15)00471-7. Epub 2015 Oct 19.
3
Healthcare professionals' views on patient-centered care in hospitals.医疗保健专业人员对医院以患者为中心的护理的看法。
BMC Health Serv Res. 2015 Sep 16;15:385. doi: 10.1186/s12913-015-1049-z.
4
Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial.65 岁或以上早期乳腺癌女性中保乳手术联合或不联合放疗(PRIME II):一项随机对照试验。
Lancet Oncol. 2015 Mar;16(3):266-73. doi: 10.1016/S1470-2045(14)71221-5. Epub 2015 Jan 28.
5
Accelerated partial breast irradiation using intensity-modulated radiotherapy versus whole breast irradiation: 5-year survival analysis of a phase 3 randomised controlled trial.调强放射治疗加速部分乳腺照射与全乳照射的比较:一项3期随机对照试验的5年生存分析
Eur J Cancer. 2015 Mar;51(4):451-463. doi: 10.1016/j.ejca.2014.12.013. Epub 2015 Jan 17.
6
Shared decision making and patient decision aids: knowledge, attitudes, and practices among Hawai'i physicians.共同决策与患者决策辅助工具:夏威夷医生的知识、态度和实践
Hawaii J Med Public Health. 2013 Nov;72(11):396-400.
7
Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343.早期乳腺癌且年龄 70 岁及以上的女性行保乳手术加他莫昔芬与或不加放疗:CALGB 9343 的长期随访结果
J Clin Oncol. 2013 Jul 1;31(19):2382-7. doi: 10.1200/JCO.2012.45.2615. Epub 2013 May 20.
8
Radiotherapy or tamoxifen after conserving surgery for breast cancers of excellent prognosis: British Association of Surgical Oncology (BASO) II trial.保乳手术后预后良好的乳腺癌行放疗或他莫昔芬治疗:英国外科肿瘤学会(BASO)II 期临床试验。
Eur J Cancer. 2013 Jul;49(10):2294-302. doi: 10.1016/j.ejca.2013.02.031. Epub 2013 Mar 21.
9
Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials.保乳手术后放疗对 10 年复发和 15 年乳腺癌死亡的影响:17 项随机试验中 10801 名女性患者个体数据的荟萃分析。
Lancet. 2011 Nov 12;378(9804):1707-16. doi: 10.1016/S0140-6736(11)61629-2. Epub 2011 Oct 19.
10
Systematic review of the effects of shared decision-making on patient satisfaction, treatment adherence and health status.共享决策对患者满意度、治疗依从性和健康状况影响的系统评价。
Psychother Psychosom. 2008;77(4):219-26. doi: 10.1159/000126073. Epub 2008 Apr 16.